Blue California Commercializes Nicotinamide Mononucleotide (NMN) for Supporting an Increased Healthspan Rancho Santa Margarita, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Blue California joins with the innovative Massachusetts-based biotech company Conagen to announce the commercialization of...

Effepharm Announced Acquisitions and New R&D Center Establishment SHANGHAI, China, Dec. 12, 2019 (GLOBE NEWSWIRE) -- Effepharm announce that they acquired two bio-pharmaceutical companies recently, named Dendrimer Co. and Folvo Co., the acquisition has enhanced...